Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 164 Records) |
Query Trace: Syndrome and CYP2C19[original query] |
---|
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients. Molecular diagnosis & therapy 2021 8 25 (6): 735-755. Hirata Thiago Dominguez Crespo, Dagli-Hernandez Carolina, Genvigir Fabiana Dalla Vecchia, Lauschke Volker Martin, Zhou Yitian, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Cres |
The influence of acute coronary syndrome on levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19*2(681 G>A), *3(636 G>A) and ABCB1(C3435C> T) gene polymorphisms. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology 2021 Jun 17 (2): 179-186. Wójcik Tomasz, Karolko Bo?ena, Wi?niewski Jerzy, Mysiak Andrzej, ?ciborski Krzysztof, Onisk Grzegorz, Lebioda Arleta, Jonkisz Anna, Protasiewicz Marc |
Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study. BMC cardiovascular disorders 2021 Aug 21 (1): 391. Yu Luhai, Wang Tingting, Bai Huidong, Zhu Weijiang, Li Yanju, Wu Jianhua, Liu Wenli, Sun Li, Yu Aiping, Li Hongji |
Effects of aging on clinical outcomes in patients receiving genotype-guided P2Y12 inhibitor selection after percutaneous coronary intervention. Pharmacotherapy 2021 Jul . Wood Brian, Lee Craig R, Mulrenin Ian R, Gower Megan N, Rossi Joseph S, Weck Karen E, Stouffer George |
Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol. Drug metabolism and disposition: the biological fate of chemicals 2021 7 49 (10): 882-891. Beers Jessica L, Fu Dong, Jackson Klarissa |
MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction. Pharmacogenomics and personalized medicine 2021 12 14 1575-1582. Rytkin Eric, Mirzaev Karin, Bure Irina, Akmalova Kristina, Abdullaev Sherzod, Kachanova Anastasiia, Smirnov Valery, Grishina Elena, Lyakhova Natalia, Aleshkovich Elena, Saribekian Anna, Andreev Denis, Shabunin Alexey, Sychev Dmit |
Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome. Hospital pharmacy 2021 Oct 56 (5): 592-596. Skryabin Valentin Yurievich, Zastrozhin Mikhail, Torrado Marco, Grishina Elena, Ryzhikova Kristina, Shipitsyn Valery, Galaktionova Tatiana, Sorokin Alexander, Bryun Evgeny, Sychev Dmit |
Clinical Outcomes After Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms. Journal of cardiovascular pharmacology 2021 Oct . Zhang Yang, Zhao Xiliang, Ye Yicong, Li Quan, Zeng Yo |
Semi-mechanistic population pharmacokinetics analysis reveals distinct CYP2C19 dependency in the bioactivation of vicagrel and clopidogrel to active metabolite M15-2. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2022 7 177 106264. Zhang Lin, Sun Hongbin, Liu Yongqiang, Lai Xiaojuan, Gong Yanchun, Liu Xuefang, Li Yong-Guo, He Yang, Zhang Eric Y, Yan Xiao |
The Cytochrome P450 2C19 Polymorphism Associated with Major Adverse Cardiovascular Events Risk in Kazak Patients Undergoing Percutaneous Coronary Intervention and Receiving Clopidogrel. Endocrine, metabolic & immune disorders drug targets 2022 May . Wang Tingting, Feng Jie, Zhou Liying, Zhao Ting, Zhang Huilan, Shen Hao, Xu Li, Sun Li, Wu Jianhua, Li Hongjian, Yu Luh |
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.
Translational psychiatry 2022 4 12 (1): 145. Okhuijsen-Pfeifer C, van der Horst M Z, Bousman C A, Lin B, van Eijk K R, Ripke S, Ayhan Y, Babaoglu M O, Bak M, Alink W, van Beek H, Beld E, Bouhuis A, Edlinger M, Erdogan I M, Ertu?rul A, Yoca G, Everall I P, Görlitz T, , Grootens K P, Gutwinski S, Hallikainen T, Jeger-Land E, de Koning M, Lähteenvuo M, Legge S E, Leucht S, Morgenroth C, Müderriso?lu A, Narang A, Pantelis C, Pardiñas A F, Oviedo-Salcedo T, Schneider-Thoma J, Schreiter S, Repo-Tiihonen E, Tuppurainen H, Veereschild M, Veerman S, de Vos M, Wagner E, Cohen D, Bogers J P A M, Walters J T R, Ya?c?o?lu A E Anil, Tiihonen J, Hasan A, Luykx J |
Development and Validation of a Novel Tool for the Prediction of Clopidogrel Response in Chinese Acute Coronary Syndrome Patients: The GeneFA Score. Frontiers in pharmacology 2022 4 13 854867. Wu Hongyi, Li Xiaoye, Qian Juying, Zhao Xin, Yao Yao, Lv Qianzhou, Ge Jun |
Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study. Journal of the Formosan Medical Association = Taiwan yi zhi 2022 2 121 (9): 1786-1797. Kuo Feng-Yu, Lee Cheng-Han, Lan Wei-Ren, Su Cheng-Huang, Lee Wen-Lieng, Wang Yi-Chih, Lin Wei-Shiang, Chu Pao-Hsien, Lu Tse-Min, Lo Ping-Han, Tsukiyama Shuji, Yang Wei-Chen, Cheng Li-Chung, Huang Chien-Lung, Yin Wei-Hsian, Liu Ping-Y |
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation. Pharmacology 2022 Jan 1-11. Baturina Olga, Andreev Denis, Fedina Ludmila, Mirzaev Karin, Ivashchenko Dmitriy, Ryzhikova Kristina, Grishina Elena, Bochkov Pavel, Shevchenko Roman, Sychev Dmitr |
Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis. Pharmacogenomics 2022 1 23 (3): 207-220. Biswas Mohitosh, Sukasem Chonlaphat, Khatun Kali Most Sumaiya, Ibrahim Baharud |
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Cardiovascular revascularization medicine : including molecular interventions 2022 1 41 115-121. Malik Aaqib H, Gupta Rahul, Chakraborty Sandipan, Mahajan Pranav, Bandyopadhyay Dhrubajyoti, Yandrapalli Srikanth, Zaid Syed, Sreenivasan Jayakumar, Chaturvedi Abhishek, Mehta Sanjay S, Vyas Apurva V, Patel Nainesh C, Combs William G, Ahmad Has |
Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome. Psychiatric genetics 2022 1 32 (2): 67-73. Skryabin Valentin Yurievich, Zastrozhin Mikhail, Torrado Marco, Grishina Elena, Ryzhikova Kristina, Shipitsyn Valery, Galaktionova Tatiana, Bryun Evgeny, Sychev Dmit |
CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel. Clinical and translational science 2023 8 . Markus Ramste, Markus Ritvos, Sergei Häyrynen, Johanna I Kiiski, Mikko Niemi, Juha Sinisa |
Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention. JACC. Cardiovascular interventions 2023 4 16 (7): 829-843. Lee Seung Hun, Jeong Young-Hoon, Hong David, Choi Ki Hong, Lee Joo Myung, Park Taek Kyu, Yang Jeong Hoon, Hahn Joo-Yong, Choi Seung-Hyuck, Gwon Hyeon-Cheol, Jeong Myung Ho, Kim Byeong-Keuk, Joo Hyung Joon, Chang Kiyuk, Park Yongwhi, Ahn Sung Gyun, Suh Jung-Won, Lee Sang Yeub, Cho Jung Rae, Her Ae-Young, Kim Hyo-Soo, Kim Moo Hyun, Lim Do-Sun, Shin Eun-Seok, Song Young Bin, |
CD80 DNA methylation and single-nucleotide polymorphism associated with clopidogrel response: a whole-genome DNA methylation analysis in acute coronary syndrome. Research and practice in thrombosis and haemostasis 2023 3 7 (2): 100093. Song Pei-Yuan, Li Mu-Peng, Peng Li-Ming, Chen Xiao-Pi |
Cytochrome P450 2C19 Polymorphisms and Its Association With Major Adverse Cardiac Events in Post-coronary Intervention Patients on Clopidogrel in the Tertiary Care Center. Cureus 2023 3 15 (2): e34737. Kambhampati Nikhil Teja, Ahamed Hisham, K K Velayudhan, David Sachin, Hakeem Sai Chandra, Pillai Gopalakrishna, Kartha Nivedit |
Clinical Impact of the CYP2C19 Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome. Journal of personalized medicine 2023 2 13 (2): . Ho Teresa T, Noble Melissa, Tran Bao Anh, Sunjic Katlynd, Gupta Sheeba Varghese, Turgeon Jacques, Crutchley Rustin |
miR-6076 rs1463411 polymorphisms are associated with bleeding during clopidogrel treatment in patients with acute coronary syndrome. European journal of medical research 2023 2 28 (1): 96. Mo Zhen-Zhen, Yuan Zhen, Peng Yuan-Yuan, Zhou Wan-Lu, Dai Wei, Wang Guo, Tang Jie, Zhang Wei, Chen Bi-Li |
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes. Archives of pharmacal research 2023 12 . Chang-Keun Cho, Eunvin Ko, Ju Yeon Mo, Pureum Kang, Choon-Gon Jang, Seok-Yong Lee, Yun Jeong Lee, Jung-Woo Bae, Chang-Ik Ch |
Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance. JPMA. The Journal of the Pakistan Medical Association 2023 12 73 (12): 2388-2392. Usman Nawaz, Mudassar Noor, Akbar Wahe |
Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions. Neurogastroenterology and motility 2023 12 e14722. Revati Varma, Jeffrey P Staab, Eric T Matey, Jessica A Wright, Brototo Deb, Konstantinos N Lazaridis, Lawrence A Szarka, Kent R Bailey, Adil E Bharuc |
The combination of CYP2C19 polymorphism and inflammatory cell ratios in prognosis cardiac adverse events after acute coronary syndrome. International journal of cardiology. Cardiovascular risk and prevention 2023 11 19 200222. Toan Hoang Ngo, Nha Tran Khuong Nguyen, Nga Thi Ngoc Pham, Bao Lam Thai Tran, An Tuan Huynh, Khue Duy Nguyen, Khuong Duy Nguyen, An Viet Tr |
Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians. The journal of gene medicine 2023 11 e3634. Keshavamurthy Ganapathy Bhat, Ratheesh Kumar Janardhana Pillai, Heemanshu Lodhi, Vivek Singh Guleria, Anil Kumar Abbot, Love Gupta, Garima Rastogi, Anuka Sharma, Zafar Mohammed, Varun Shar |
CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans Program. medRxiv : the preprint server for health sciences 2023 11 . Catherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, Kyung Min Lee, Zhenyu Lu, Julie A Lynch, Scott L DuVall, Jason L Vassy, Stephen W Waldo, John H Cleator, Thomas M Maddox, Daniel J Rader, Themistocles L Assimes, Scott M Damrauer, Philip S Tsao, Kyong-Mi Chang, Deepak Voora, Jay Giri, Sony Tute |
The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry. Journal of cardiovascular pharmacology and therapeutics 2023 10 28 10742484231210704. Jaouad Azzahhafi, Wout W A van den Broek, Dean R P P Chan Pin Yin, Ankie M Harmsze, Ron H N van Schaik, Jurriën M Ten Be |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: